Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
Category: House of Representatives
-
Student Aid Woes Stalk Education Secretary in Appearance on Capitol Hill
In two hearings, House lawmakers scrutinized Miguel Cardona’s record over persistent problems with the new FAFSA form.
-
TikTok Faces a Senate Showdown
A bill to potentially ban the video app breezed through the House, but its fate is less certain in the upper chamber as Big Tech weighs the wider implications.
-
TikTok Prompts Users to Call Congress to Fight Possible Ban
Many Capitol Hill offices were inundated with phone calls after TikTok urged users to tell their representatives they opposed a new bill aimed at the company.
-
I.R.S. Commissioner Warns Budget Cuts Would Add to Deficit
Daniel Werfel, the Internal Revenue Service commissioner, pushed back against claims from Republicans that he had not been following the law.
-
American Firms Invested $1 Billion in Chinese Chips, Lawmakers Find
A Congressional investigation determined that U.S. funding helped fuel the growth of a sector now viewed by Washington as a security threat.